N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation

The ribosome utilizes hydrogen bonding between mRNA codons and aminoacyl-tRNAs to ensure rapid and accurate protein production. Chemical modification of mRNA nucleobases can adjust the strength and pattern of this hydrogen bonding to alter protein synthesis. We investigate how the N1-methylpseudouridine (m<sup>1</sup>Ψ) modification, commonly incorporated into therapeutic and vaccine mRNA sequences, influences the speed and fidelity of translation. We find that m<sup>1</sup>Ψ does not substantially change the rate constants for amino acid addition by cognate tRNAs or termination by release factors. However, we also find that m<sup>1</sup>Ψ can subtly modulate the fidelity of amino acid incorporation in a codon-position and tRNA dependent manner in vitro and in human cells. Our computational modeling shows that altered energetics of mRNA:tRNA interactions largely account for the context dependence of the low levels of miscoding we observe on Ψ and m<sup>1</sup>Ψ containing codons. The outcome of translation on modified mRNA bases is thus governed by the sequence context in which they occur.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-09-16
DOI
https://doi.org/10.1038/s41467-024-51301-0
Citations
41
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
9.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation

Kristin S. Koutmou, Pooja Srinivas, C.M. Dunham, Aaron T. Frank et al.
41 citations
Nature Communications
RNA modifications and cancer
9.35
article

N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation

Kristin S. Koutmou, Pooja Srinivas, C.M. Dunham, Aaron T. Frank, Lili Mitchell, Indrajit Deb, Bijoyita Roy, Jeremy Monroe, Daniel E. Eyler, Abigail Bojanowski
article en
41 citations

Abstract

The ribosome utilizes hydrogen bonding between mRNA codons and aminoacyl-tRNAs to ensure rapid and accurate protein production. Chemical modification of mRNA nucleobases can adjust the strength and pattern of this hydrogen bonding to alter protein synthesis. We investigate how the N1-methylpseudouridine (m<sup>1</sup>Ψ) modification, commonly incorporated into therapeutic and vaccine mRNA sequences, influences the speed and fidelity of translation. We find that m<sup>1</sup>Ψ does not substantially change the rate constants for amino acid addition by cognate tRNAs or termination by release factors. However, we also find that m<sup>1</sup>Ψ can subtly modulate the fidelity of amino acid incorporation in a codon-position and tRNA dependent manner in vitro and in human cells. Our computational modeling shows that altered energetics of mRNA:tRNA interactions largely account for the context dependence of the low levels of miscoding we observe on Ψ and m<sup>1</sup>Ψ containing codons. The outcome of translation on modified mRNA bases is thus governed by the sequence context in which they occur.

Nature CommunicationsVol. 15(1)
New England Biolabs (United States) (US), Emory University (US), University of Michigan (US), Arrakis Therapeutics (United States) (US)
National Science Foundation, Research Corporation for Science Advancement, National Institutes of Health, National Institute of General Medical Sciences
Openalex Percentile: Top 1%
RNA modifications and cancer
9.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.